...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of prosthetics and orthotics: JPO >Cost-Effectiveness of Transtibial Bone-Anchored Prostheses Using Osseointegrated Fixation: From Challenges to Preliminary Data
【24h】

Cost-Effectiveness of Transtibial Bone-Anchored Prostheses Using Osseointegrated Fixation: From Challenges to Preliminary Data

机译：使用骨整合固定进行宁骨锚定假体的成本效益：从初步数据的挑战

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Introduction: This initial cost-effectiveness evaluation compared the provision of transtibial bone-anchored prostheses (TTA-BAPs) with socket-suspended prostheses (TTA-SSPs) over a 6-year time horizon from a governmental prosthetic care perspective. The purposes were to present ways we dealt with barriers encountered during the cost-effectiveness analysis. The objectives were to detail the extraction of baseline and incremental costs and utilities required to provide preliminary incremental cost-effectiveness ratios (ICERs) per quality-adjusted life-year (QALY). Materials and Methods: This retrospective case-series study involved six participants fitted consecutively with TTA-SSP and TTA-BAP. Total costs combined actual and typical costs extracted from financial records and a schedule of allowable expenses, respectively. Baseline utilities were extracted from the literature, whereas incremental utilities were assumed. Results: ICERs ranged between -$25,065 and $41,929 per QALY. Indicative ICER was approximately $11,400 per QALY. Provision of TTA-BAP was cost-effective and cost saving for 83% and 33% of cases, respectively. Discussion: Educated choices were required to overcome unavailability of individual costs (e.g., creation of schedule of allowable expenses, blending of actual and typical costs) and utilities (e.g., extraction of baseline from literature, assumptions for incremental gain). Indicative ICER might lead to adoption of TTA-BAP, at least from an Australian governmental prosthetic care perspective.
机译：导言：从政府假肢护理的角度，这项初步的成本效益评估比较了6年内提供的经胫骨骨锚定假肢（TTA BAPs）和套筒悬挂假肢（TTA SSPs）。目的是展示我们在成本效益分析中应对障碍的方法。目标是详细说明基准成本和增量成本的提取，以及提供每个质量调整寿命年（QALY）的初步增量成本效益比（ICER）所需的公用设施。材料和方法：这项回顾性病例系列研究涉及六名连续使用TTA-SSP和TTA-BAP的参与者。总成本分别是从财务记录和允许费用表中提取的实际成本和典型成本的总和。基线效用是从文献中提取的，而增量效用是假设的。结果：ICER在-25065美元到41929美元之间。指示性ICER约为每QALY 11400美元。在83%和33%的病例中，TTA-BAP的提供分别具有成本效益和成本节约。讨论：需要经过教育的选择，以克服单个成本（例如，创建允许费用计划，混合实际和典型成本）和公用事业（例如，从文献中提取基线，对增量收益的假设）的不可用性。指示性ICER可能会导致采用TTA-BAP，至少从澳大利亚政府的假肢护理角度来看是这样。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号